These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3402461)

  • 1. Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias.
    Facchini M; Bonazzi O; Priori SG; Varisco T; Zuanetti G; Schwartz PJ
    Eur Heart J; 1988 May; 9(5):462-70. PubMed ID: 3402461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
    Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
    Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L; Myburgh DP; Schamroth CL; Scholtz ME; Pincus DR; Kawalsky DL
    Chest; 1985 Apr; 87(4):448-51. PubMed ID: 3884286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening of arrhythmias during pharmacological treatment.
    Furlanello F; Gramegna L; Dal Forno P; Vergara G; Bettini R; Inama G; Disertori M
    G Ital Cardiol; 1984 Oct; 14(10):798-803. PubMed ID: 6440827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF; Morganroth J
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
    Naccarella F; Bracchetti D; Palmieri M; Cantelli I; Bertaccini P; Ambrosioni E
    Am Heart J; 1985 Apr; 109(4):833-40. PubMed ID: 3885700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of disopyramide, mexiletine and propafenon after intravenous and oral administration on left ventricular function in the M-mode echocardiogram].
    Böcker K; Köhler E; Seipel L; Loogen F
    Z Kardiol; 1982 Dec; 71(12):839-45. PubMed ID: 7164536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study.
    Härtel G
    Eur Heart J; 1985 Feb; 6(2):123-9. PubMed ID: 3891347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).
    Zuanetti G; Latini R; Neilson JM; Schwartz PJ; Ewing DJ
    J Am Coll Cardiol; 1991 Mar; 17(3):604-12. PubMed ID: 1899680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine. Long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias.
    Kerin NZ; Aragon E; Marinescu G; Faitel K; Frumin H; Rubenfire M
    Arch Intern Med; 1990 Feb; 150(2):381-4. PubMed ID: 2302013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease.
    Moak JP; Smith RT; Garson A
    J Am Coll Cardiol; 1987 Oct; 10(4):824-9. PubMed ID: 3655149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antiarrhythmic drugs.
    Nestico PF; Morganroth J; Horowitz LN
    Drugs; 1988 Mar; 35(3):286-319. PubMed ID: 3286214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
    Harron DW; Brogden RN
    Drugs; 1987 Dec; 34(6):617-47. PubMed ID: 3322781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
    Tanabe T
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():827-34. PubMed ID: 1931759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.